Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Bortezomib2件: Bortezomib (Bortezomib),
Bortezomib D-mannitol (Bortezomib D-mannitol)		1件: Bortezomib (Bortezomib, BORTEZOMIB) 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬16件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 172, 222, 228, 256, 288, 331 💬
2Bortezomib accord2件: Bortezomib (Bortezomib),
Bortezomib D-mannitol (Bortezomib D-mannitol)		1件: Bortezomib (Bortezomib, BORTEZOMIB) 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
3Bortezomib D-mannitol2件: Bortezomib (Bortezomib),
Bortezomib D-mannitol (Bortezomib D-mannitol)		1件: Bortezomib (Bortezomib, BORTEZOMIB) 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
4Bortezomib injection1件: Bortezomib (Bortezomib)1件: Bortezomib (Bortezomib, BORTEZOMIB) 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 64 💬
5Bortezomib/dexamethasone1件: Bortezomib (Bortezomib)1件: Bortezomib (Bortezomib, BORTEZOMIB) 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 283 💬
6Bortezomib/dexamethasone (BD), followed BY autologous STC & maintenance bortezomib/dexamethasone1件: Bortezomib (Bortezomib)1件: Bortezomib (Bortezomib, BORTEZOMIB) 💬 1件: PSMB5 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬1件: 28 💬
7Combination OF A single dose ANTI-CD20 antibody and bortezomib----1件: 61 💬
8Cyclophosphamide, bortezomib, and dexamethasone (cybord) regimen1件: Cyclophosphamide2件: Cyclophosphamide ,
Cyclophosphamide 💬 		--1件: 28 💬
9Live combined bacillus subtilis and enterococcus faecium enteric-coated capsules combined with bortezomib+dexamethasone/bortezomib+dexamethasone+daratumumab/single daratumumab3件: Bortezomib (Bortezomib),
Daratumumab,
Dexamethasone		5件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib (Bortezomib, BORTEZOMIB),
Dexamethasone phosphate ,
Daratumumab 💬 		3件: CD38,
NR3C1,
PSMB5 💬 		15件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬1件: 28 💬